Beata Piovesan

566 total citations
5 papers, 374 citations indexed

About

Beata Piovesan is a scholar working on Oncology, Ophthalmology and Genetics. According to data from OpenAlex, Beata Piovesan has authored 5 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Ophthalmology and 2 papers in Genetics. Recurrent topics in Beata Piovesan's work include Cancer-related Molecular Pathways (3 papers), Ocular Oncology and Treatments (3 papers) and Nonmelanoma Skin Cancer Studies (1 paper). Beata Piovesan is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Ocular Oncology and Treatments (3 papers) and Nonmelanoma Skin Cancer Studies (1 paper). Beata Piovesan collaborates with scholars based in Canada, United States and India. Beata Piovesan's co-authors include Brenda L. Gallie, Vikas Khetan, M Orlic-Milacic, Paula Marrano, Helen Dimaras, Jeremy A. Squire, Ralph C. Eagle, Timothy W. Corson, William Halliday and Diane Rushlow and has published in prestigious journals such as Oncogene, Human Molecular Genetics and Journal of Medical Genetics.

In The Last Decade

Beata Piovesan

5 papers receiving 368 citations

Peers

Beata Piovesan
Beata Piovesan
Citations per year, relative to Beata Piovesan Beata Piovesan (= 1×) peers Suzanne Richter

Countries citing papers authored by Beata Piovesan

Since Specialization
Citations

This map shows the geographic impact of Beata Piovesan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beata Piovesan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beata Piovesan more than expected).

Fields of papers citing papers by Beata Piovesan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beata Piovesan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beata Piovesan. The network helps show where Beata Piovesan may publish in the future.

Co-authorship network of co-authors of Beata Piovesan

This figure shows the co-authorship network connecting the top 25 collaborators of Beata Piovesan. A scholar is included among the top collaborators of Beata Piovesan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beata Piovesan. Beata Piovesan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Racher, Hilary, Sameh E. Soliman, Bob Argiropoulos, et al.. (2016). Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma. Cancer Genetics. 209(7-8). 359–363. 8 indexed citations
2.
Piovesan, Beata, et al.. (2011). Identification of clinically relevant mosaicism in type I hereditary haemorrhagic telangiectasia. Journal of Medical Genetics. 48(5). 353–357. 12 indexed citations
3.
Rushlow, Diane, et al.. (2009). Detection of mosaicRB1mutations in families with retinoblastoma. Human Mutation. 30(5). 842–851. 104 indexed citations
4.
Dimaras, Helen, Vikas Khetan, William Halliday, et al.. (2008). Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Human Molecular Genetics. 17(10). 1363–1372. 229 indexed citations
5.
Piovesan, Beata, Nancy Pennell, & Neil L. Berinstein. (1998). Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity. Oncogene. 17(18). 2339–2350. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026